Caris Life Sciences’ scientific experts and external collaborators contribute to the advancement of science at various symposia and conferences worldwide. Posters and abstracts highlighting the clinical utility of Caris Molecular Intelligence tumor profiling are listed below.

High-Intermediate Risk Endometrial Cancer: Can Gene Expression Predict Recurrence?

Molecular Profiling for Clinical Decision Making in Advanced Cancer: A Clinical Appraisal

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy

Identification of molecular targets in vulvar cancers

Comparative molecular profiling of HPV-induced squamous cell carcinomas

BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations

Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade

RNASeq analysis of glioma tumors reveal targetable gene fusions

Localization of non-receptor tyrosine kinase (nRTK) variants identified in solid tumor patients with Next-Generation Sequencing (NGS)

Prevalence of homologous recombination deficiency among all tumor types